{
    "clinical_study": {
        "@rank": "72420", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.   Assess the efficacy of surgery vs no surgery in patients with mild\n      asymptomatic primary hyperparathyroidism.\n\n      II.  Assess the quality of life, morbidity, and mortality of these patients."
        }, 
        "brief_title": "A Randomized Study of Surgery Vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism", 
        "condition": "Hyperparathyroidism", 
        "condition_browse": {
            "mesh_term": [
                "Hyperparathyroidism", 
                "Hyperparathyroidism, Primary"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is a randomized, multicenter study.  Patients are stratified by\n      gender. Patients are randomized to receive surgery or follow up without surgery.\n\n      Patients receive parathyroidectomy (current standard care) or long term follow up without\n      parathyroidectomy.\n\n      Quality of life is assessed before the study and then every 6 months. All patients are\n      followed every 6 months until death."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics-- Histologically diagnosed mild asymptomatic primary\n        hyperparathyroidism Persistent albumin adjusted serum calcium between 10.1-11.5 mg/dL for\n        at least 3 months Intact parathyroid hormone greater than 20 pg/mL No other cause for\n        hypercalcemia No family history of primary hyperparathyroidism, primary endocrine\n        neoplasia, or hypocalciuric hypercalcemia Bone mineral density of the forearm no greater\n        than 2.0 SD units below the expected value for sex, age, and race No phalangeal\n        subperiosteal resorption on hand x-rays --Prior/Concurrent Therapy-- Radiotherapy: No\n        history of childhood irradiation to head and neck Surgery: No thyroid disease requiring\n        surgical intervention Other: No prior glucocorticoid or anticonvulsant drug therapy\n        Concurrent thiazide diuretic therapy for hypertension must be changed to nonthiazides\n        --Patient Characteristics-- Menopausal status: At least 5 years postmenopausal Renal: At\n        least 2 years since prior nephrolithiasis Creatinine no greater than 1.5 mg/dL Creatinine\n        clearance at least 70% (age adjusted) Cardiovascular: No unexpected finding on\n        echocardiogram that will interfere with surgical intervention Other: Living within 150\n        mile radius of downtown Detroit No concurrent participation in other clinical trials No\n        concurrent polyuria, polydipsia, anorexia, nausea, or vomiting At least 12 months since\n        prior pancreatitis No concurrent symptomatic peptic ulcer disease No objective muscle\n        weakness No history of nontraumatic vertebral or hip fractures No vertebral compression\n        fractures No urolithiasis on x-ray of abdomen"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": "100", 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004843", 
            "org_study_id": "199/13926", 
            "secondary_id": "HFH-5R01DK43858"
        }, 
        "intervention": {
            "intervention_name": "parathyroidectomy", 
            "intervention_type": "Procedure"
        }, 
        "keyword": [
            "disease-related problem/condition", 
            "endocrine disorders", 
            "hyperparathyroidism", 
            "quality of life", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Henry Ford Hospital", 
            "last_name": "D. Sudhaker Rao", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004843"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Henry Ford Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 1994", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 1998"
    }, 
    "geocoordinates": {}
}